Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss

Osteoporosis is characterized by bone loss and destruction of trabecular architecture, which greatly increases the burden on the healthcare system. Excessive activation of osteoclasts is an important cause of osteoporosis, and suppression of osteoclastogenesis is helpful for the treatment of osteopo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Qi, Dahu, Liu, Hui, Sun, Xuying, Luo, Danni, Zhu, Meipeng, Tao, Tenghui, Gao, Chenghao, Zhou, Chuankun, Zhou, Wei, Xiao, Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898668/
https://ncbi.nlm.nih.gov/pubmed/33628184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.621110
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados